Dr Nicholas Glanville
Nicholas is a Principal Scientist with over 13 years’ experience in virology and immunology research prior to joining Virtus, most recently having spent 2 years at another CRO.
Having obtained his PhD at Imperial College London, his academic work focused on both innate and adaptive immune responses to respiratory virus infections, with a particular focus on T cell function and vaccine development. He has extensive experience with in vivo and in vitro models of rhinovirus infection.
Nicholas manages the lab side of Virtus’s operations, bringing to bear this experience on client projects from study design to delivery.